178 related articles for article (PubMed ID: 27893466)
1. CD30 Expression Is Rare in Myeloid Leukemia Cutis: A Study of 55 Cases and Implications for Routine Diagnostic Algorithms.
Ogunrinade O; Terrano D; Chiu A; Pulitzer M
Am J Dermatopathol; 2017 May; 39(5):351-357. PubMed ID: 27893466
[TBL] [Abstract][Full Text] [Related]
2. Expression of JL1 is an effective adjunctive marker of leukemia cutis.
Park YS; Park SH; Park SJ; Kim Y; Jang KT; Ko YH; Lee MW; Huh JR; Park CS
Arch Pathol Lab Med; 2010 Jan; 134(1):95-102. PubMed ID: 20073611
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia.
Hurley MY; Ghahramani GK; Frisch S; Armbrecht ES; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
Acta Derm Venereol; 2013 May; 93(3):319-24. PubMed ID: 23165700
[TBL] [Abstract][Full Text] [Related]
4. CD30 Expression in Pediatric Neoplasms, Study of 585 Cases.
Cheng J; Zhu H; Choi JK
Pediatr Dev Pathol; 2017 Jun; 20(3):191-196. PubMed ID: 28521633
[TBL] [Abstract][Full Text] [Related]
5. Leukemia cutis as the presenting symptom of acute myeloid leukemia: report of three cases.
Moyer AB; Rembold J; Lee NE; Johnson G; Gardner JM
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142735
[TBL] [Abstract][Full Text] [Related]
6. CD30 expression in high-risk acute myeloid leukemia and myelodysplastic syndromes.
Zheng W; Medeiros LJ; Hu Y; Powers L; Cortes JE; Ravandi-Kashani F; Kantarjian HH; Wang SA
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):307-14. PubMed ID: 23313069
[TBL] [Abstract][Full Text] [Related]
7. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
[TBL] [Abstract][Full Text] [Related]
8. Myeloid leukemia cutis: a histologic and immunohistochemical review.
Cibull TL; Thomas AB; O'Malley DP; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):180-5. PubMed ID: 18190442
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
[TBL] [Abstract][Full Text] [Related]
10. Aleukemia cutis: Clinicopathological and molecular investigation of two cases.
Azari-Yaam A; Safavi M; Ghanadan A
J Cutan Pathol; 2020 Aug; 47(8):747-754. PubMed ID: 32196719
[TBL] [Abstract][Full Text] [Related]
11. Cytophagic and S-100 protein immunoreactive myeloid leukemia cutis.
Thomas CG; Patel RM; Bergfeld WF
J Cutan Pathol; 2010 Mar; 37(3):390-5. PubMed ID: 19615019
[TBL] [Abstract][Full Text] [Related]
12. Linear Folliculotropic CD30-Positive Lymphomatoid Drug Reaction.
Chen YC; Wu YH
Am J Dermatopathol; 2017 May; 39(5):e62-e65. PubMed ID: 27893468
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
14. ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin.
Xu B; Naughton D; Busam K; Pulitzer M
Am J Dermatopathol; 2016 Sep; 38(9):672-7. PubMed ID: 26909589
[TBL] [Abstract][Full Text] [Related]
15. Leukemia cutis - A case of cutaneous manifestation of acute monoblastic leukemia.
Mandal AP; Das R; Sengupta M; Chatterjee U
J Cancer Res Ther; 2023; 19(3):826-828. PubMed ID: 37470620
[TBL] [Abstract][Full Text] [Related]
16. CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases.
Alimchandani M; Wang ZF; Miettinen M
Appl Immunohistochem Mol Morphol; 2014; 22(5):358-62. PubMed ID: 24805132
[TBL] [Abstract][Full Text] [Related]
17. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis.
Pina-Oviedo S; Torres-Cabala CA; Miranda RN; Tetzlaff MT; Singh S; Rapini RP; Prieto VG; Aung PP
Am J Dermatopathol; 2017 May; 39(5):388-392. PubMed ID: 27759701
[TBL] [Abstract][Full Text] [Related]
18. Leukemia Cutis: A Report of 17 Cases and a Review of the Literature.
Martínez-Leboráns L; Victoria-Martínez AM; Torregrosa-Calatayud JL; Alegre de Miquel V
Actas Dermosifiliogr; 2016 Nov; 107(9):e65-e69. PubMed ID: 27210518
[TBL] [Abstract][Full Text] [Related]
19. A Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder Arising in a Patient With Multiple Myeloma and Cutaneous Amyloidosis.
Romano RC; Cohen DN; Howard MT; Wieland CN
Am J Dermatopathol; 2016 May; 38(5):388-92. PubMed ID: 26981738
[TBL] [Abstract][Full Text] [Related]
20. Leukemia cutis from CD56 positive, myeloperoxidase negative acute myeloid leukemia.
Abdou AG; Seleit I; Bakry OA; Abdel-Wahed MM
Acta Dermatovenerol Croat; 2013; 21(3):189-92. PubMed ID: 24183224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
